Valproate Sodium

CHEMBL433 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
166.2 g/mol
LogP
Phase
4

Valproate sodium (sodium valproate) is the sodium salt of valproic acid, a broad-spectrum antiepileptic agent that enhances GABA-ergic neurotransmission, inhibits voltage-gated sodium channels, and blocks T-type calcium channels to stabilize neuronal membranes and reduce seizure activity. It is used for epilepsy (multiple seizure types), bipolar disorder (mood stabilization), and migraine prophylaxis. Its histone deacetylase inhibitor activity has led to investigation as an epigenetic modifier in cancer.

Berat Molekul

166,1900 g/mol

TPSA

40,10 Ų

Area Terapeutik

Mekanisme Kerja

Enhances GABA transmission and blocks sodium/calcium channels.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Enhances GABA transmission and blocks sodium/calcium channels.

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCC(CCC)C(=O)[O-].[Na+]

InChI

InChI=1S/C8H16O2.Na/c1-3-5-7(6-4-2)8(9)10;/h7H,3-6H2,1-2H3,(H,9,10);/q;+1/p-1

Molecular Formula

C8H15NaO2

HBD / HBA

- / 2

Ikatan yang Dapat Dirotasi

5

Atom Berat

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

Valproate sodium (sodium valproate) is the sodium salt of valproic acid, a broad-spectrum antiepileptic agent that enhances GABA-ergic neurotransmission, inhibits voltage-gated sodium channels, and blocks T-type calcium channels to stabilize neuronal membranes and reduce seizure activity. It is used for epilepsy (multiple seizure types), bipolar disorder (mood stabilization), and migraine prophylaxis. Its histone deacetylase inhibitor activity has led to investigation as an epigenetic modifier in cancer.

Enhances GABA transmission and blocks sodium/calcium channels.

Yes, Valproate Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL433. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 16760703. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.